Analyzing Trulieve Cannabis (TRLV) & Its Competitors

Trulieve Cannabis (NYSE:TRLV) is one of 899 publicly-traded companies in the “Pharmaceuticals” industry, but how does it contrast to its rivals? We will compare Trulieve Cannabis to similar companies based on the strength of its risk, analyst recommendations, dividends, earnings, valuation, profitability and institutional ownership.

Insider & Institutional Ownership

32.6% of shares of all “Pharmaceuticals” companies are held by institutional investors. 3.8% of Trulieve Cannabis shares are held by company insiders. Comparatively, 14.1% of shares of all “Pharmaceuticals” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Analyst Ratings

This is a summary of recent ratings for Trulieve Cannabis and its rivals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Trulieve Cannabis	1	1	1	0	2.00
Trulieve Cannabis Competitors	7687	13769	25576	1016	2.41

Trulieve Cannabis presently has a consensus target price of $15.00, indicating a potential upside of 41.02%. As a group, “Pharmaceuticals” companies have a potential upside of 39.69%. Given Trulieve Cannabis’ higher possible upside, research analysts clearly believe Trulieve Cannabis is more favorable than its rivals.

Profitability

This table compares Trulieve Cannabis and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Trulieve Cannabis	-41.55%	-4.24%	-1.72%
Trulieve Cannabis Competitors	-2,378.12%	-221.74%	-16.00%

Valuation and Earnings

This table compares Trulieve Cannabis and its rivals revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Trulieve Cannabis	$1.14 billion	-$116.38 million	96.70
Trulieve Cannabis Competitors	$3.52 billion	$3.17 billion	551.48

Trulieve Cannabis’ rivals have higher revenue and earnings than Trulieve Cannabis. Trulieve Cannabis is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Summary

Trulieve Cannabis rivals beat Trulieve Cannabis on 8 of the 12 factors compared.

Trulieve Cannabis Company Profile

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, California, Massachusetts, Connecticut, Pennsylvania, and West Virginia, as well as directly to patients through home delivery. It produces approximately 550 stock keeping units, including flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays. As of May 5, 2021, the company operated through 87 dispensaries in the United States. The company is headquartered in Quincy, Florida.